Immtech Pharmaceuticals, Inc.

Management Team

Eric L. Sorkin
Chairman and Chief Executive Officer
- BIO

Cecilia Chan
Vice Chairman
- BIO

Gary C. Parks
Secretary, Treasurer and Chief Financial Officer
- BIO

Carol Ann Olson, M.D., PhD
Senior Vice President of Pharmaceutical Development and Chief Medical Officer
- BIO

Norman A. Abood, PhD
Senior Vice President, Discovery Programs
- BIO

Daniel M. Schmitt
Senior Vice President, Licensing and Commercial Development

Mr. Schmitt is responsible for development and execution of commercial strategies for Immtech’s
pipeline of products. Mr. Schmitt has 20 years of industry experience in product planning and business
development, having held similar positions in both large pharmaceutical and small biotechnology
companies. Most recently, Mr. Schmitt was at First Genetic Trust (FGT), where he served as Director
of Academic Partnerships. Prior to joining FGT, Mr. Schmitt was Director of Global Oncology at
Searle/Pharmacia, where he headed the commercial teams for Searle’s anti-angiogenesis, immunotherapy,
and cancer vaccine programs. During his career, Daniel has led and contributed to the successful
development and launch of over 12 pharmaceutical products. Mr. Schmitt received his M.B.A and a
B.S. in Chemistry from West Virginia University and has held research positions affiliated with the
National Foundation for Cancer Research and at the University of North Carolina, School of Medicine.